EXL01 in Combination With Nivolumab for Advanced NSCLC Refractory to Immunotherapy.

Clinical trial NCT06448572 · RECRUITING

Trial details

NCT number: NCT06448572
Sponsor: University Hospital, Lille
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer

Start date: 2024-07-16
Primary completion: 2028-10-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.